Pricing Log in Create free account

Neuraxis, Inc. (NRXS) vs Tiziana Life Sciences Ltd (TLSA)

Neuraxis, Inc. and Tiziana Life Sciences Ltd are both Biotechnology companies. Neuraxis, Inc. and Tiziana Life Sciences Ltd are of similar size ($86.2M and $81.9M). Tiziana Life Sciences Ltd has the higher net margin (0.00% vs −159.0%) and the higher return on invested capital (0.00% vs 0.00%). Across the 10 metrics below, Tiziana Life Sciences Ltd leads on 6 and Neuraxis, Inc. on 4.

Valuation

Metric NRXS TLSA Biotechnology median
P/E n/m n/m 10.26
P/S 13.79 — 9.18
P/B 10.89 n/m 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA n/m 0.04 0.65
EV/Sales 12.23 n/m 8.98
Earnings yield (12.89%) (84.48%) (34.89%)
Free cash flow yield (7.88%) 0.00% (24.52%)

Profitability

Metric NRXS TLSA Biotechnology median
Gross margin 85.56% 0.00% 65.16%
Operating margin (144.51%) — 0.00%
Net margin (159.01%) 0.00% 0.00%
Free cash flow margin (106.10%) 0.00% 0.00%
Return on equity (153.96%) 0.00% (50.12%)
Return on assets (98.96%) 0.00% (45.60%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric NRXS TLSA Biotechnology median
Revenue growth (TTM) 65.22% — 6.26%
EPS growth (last fiscal year) 22.13% (45.45%) 29.88%
Revenue growth, 5-year CAGR 13.08% — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric NRXS TLSA Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 3.04 0.76 4.89
Net debt to EBITDA 0.64 0.19 1.01

Dividend

Metric NRXS TLSA Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric NRXS TLSA Biotechnology median
Market cap 86.15m 81.86m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack